Cancer
Malignant Cervical Neoplasm
CI-CAN-00007992Explore in graph →
Top-level506 active trials4 approved drugs14 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00007992Explore in graph →
Clinical trials
1,994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (181)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00588276 | Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00003429 | PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery | completed | N/A | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 18, 2015 |
| NCT02265120 | Primary Care Providers' Views and Understanding of Current Recommended Guidelines for Cervical Cancer Screening | completed | N/A | 1,000 | University of Southern CaliforniaOTHER | 1 | Dec 2, 2015 | clinicaltrials |
| NCT00059787 | Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma | completed | Phase 2 | 56 | National Cancer Institute (NCI)NIH | 1 | Dec 1, 2015 | clinicaltrials |
| NCT00520598 | Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) | completed | Phase 2 | 511 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 26, 2015 | clinicaltrials |
| NCT00057863 | Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer | completed | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02605941 | DNA Methylation Biomarkers for Cervical Cancer Screening | unknown | — | 5,000 | iStat Biomedical CO., Ltd.INDUSTRY | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02083848 | Detection of Loco-regional Invasion of Cervical Cancer With 7 Tesla MRI(DETECT) | completed | N/A | 23 | UMC UtrechtOTHER | 1 | Nov 3, 2015 | clinicaltrials |
| NCT02042885 | A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer | terminated | Phase 1 / Phase 2 | 79 | Otsuka Novel Products GmbHINDUSTRY | 1 | Oct 20, 2015 | clinicaltrials |
| NCT02309658 | Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients | completed | Phase 2 | 50 | Professor Fernando Figueira Integral Medicine InstituteOTHER | 1 | Oct 16, 2015 | clinicaltrials |
| NCT01096134 | Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention(MDI) | completed | N/A | 8,000 | JhpiegoOTHER | 2 | Oct 12, 2015 | clinicaltrials |
| NCT01764789 | Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer | completed | N/A | 39 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT00703196 | Folic Acid Clinical Trial for the Prevention of Cervical Cancer | completed | Phase 2 | 368 | University of Alabama at BirminghamOTHER | 1 | Oct 8, 2015 | clinicaltrials |
| NCT02253719 | Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia | completed | — | 1,000 | Sihanouk Hospital Center of HOPEOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT01039493 | Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications | completed | — | 40 | University of Wisconsin, MadisonOTHER | 1 | Oct 2, 2015 | clinicaltrials |
| NCT02367001 | Randomized Trial Evaluating the Effectiveness of the General Practitioner Involvement in Cancer Screening Invitations(GPs) | completed | N/A | 53,978 | University Hospital, ToursOTHER | 1 | Oct 1, 2015 | clinicaltrials |
| NCT00092521 | Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) | completed | Phase 3 | 5,759 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 25, 2015 | clinicaltrials |
| NCT01910350 | Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening(KinKeeper) | completed | N/A | 516 | Michigan State UniversityOTHER | 1 | Sep 25, 2015 | clinicaltrials |
| NCT02276521 | Evaluation of Long Term Immunity Following HPV Vaccination | completed | — | 200 | Murdoch Childrens Research InstituteOTHER | 1 | Sep 23, 2015 | clinicaltrials |
| NCT01026792 | Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery | completed | Phase 2 | 38 | National Cancer Institute (NCI)NIH | 1 | Sep 10, 2015 | clinicaltrials |
| NCT02039791 | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer | unknown | Phase 2 | 20 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT01652794 | Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer | completed | Phase 1 | 12 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 4, 2015 | clinicaltrials |
| NCT02510027 | Triage Strategies in Cervical Cancer Prevention(FRIDA) | unknown | — | 100,000 | Instituto Nacional de Salud Publica, MexicoOTHER | 1 | Jul 28, 2015 | clinicaltrials |
| NCT00100841 | Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer | completed | Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jul 27, 2015 | clinicaltrials |
| NCT00510250 | A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer | completed | Phase 1 / Phase 2 | 13 | University Health Network, TorontoOTHER | 1 | Jul 27, 2015 | clinicaltrials |
| NCT00233727 | Screen and Treat for Cervical Cancer Prevention(SAT) | terminated | Phase 3 | 7,123 | Columbia UniversityOTHER | 1 | Jul 9, 2015 | clinicaltrials |
| NCT00581646 | Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance | completed | — | 179 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 8, 2015 | clinicaltrials |
| NCT00365443 | Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) | withdrawn | Phase 2 | 0 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 19, 2015 | clinicaltrials |
| NCT02471027 | The Clinical Research of Neoadjuvant Chemotherapy Combined Surgery for Locally Advanced Cervical Cancer | unknown | — | 1,000 | Yu mei WuOTHER | 1 | Jun 12, 2015 | clinicaltrials |
| NCT00789893 | Study of Vaginal Dilator Use After Pelvic Radiotherapy | completed | — | 115 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT00260039 | Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001) | completed | Phase 2 | 680 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 8, 2015 | clinicaltrials |
| NCT00551187 | A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) | completed | Phase 2 | 620 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 8, 2015 | clinicaltrials |
| NCT00915889 | Psychosocial Support for African-American, Latina-American, or European-American Cervical Cancer Survivors | completed | N/A | 340 | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01709175 | Strength Training Study for Survivors of Breast and Gynecologic Cancer | completed | N/A | 20 | Nova Scotia Health AuthorityOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01485731 | Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer | completed | Phase 1 | 8 | University of MiamiOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT00003384 | Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer | completed | N/A | 684 | Gynecologic Oncology GroupNETWORK | 1 | May 29, 2015 | clinicaltrials |
| NCT00217633 | Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer | completed | Phase 2 | 38 | Gynecologic Oncology GroupNETWORK | 2 | May 29, 2015 | clinicaltrials |
| NCT02458001 | Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer(SAFFRON) | unknown | N/A | 100 | University College, LondonOTHER | 0 | May 29, 2015 | clinicaltrials |
| NCT01819077 | TMMR (Total Mesometrial Resection) Register Study(TMMR-RS) | unknown | — | 500 | University Hospital, EssenOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01773980 | CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening | completed | — | 1,570 | OHSU Knight Cancer InstituteOTHER | 1 | May 22, 2015 | clinicaltrials |
| NCT00006011 | Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | completed | Phase 3 | 659 | Gynecologic Oncology GroupNETWORK | 1 | May 19, 2015 | clinicaltrials |
| NCT01198535 | Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | May 18, 2015 | clinicaltrials |
| NCT00060359 | Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer | completed | Phase 1 | 32 | Gynecologic Oncology GroupNETWORK | 1 | May 8, 2015 | clinicaltrials |
| NCT00430781 | Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer | completed | Phase 2 | 228 | GlaxoSmithKlineINDUSTRY | 13 | May 8, 2015 | clinicaltrials |
| NCT01524003 | Chinese Cancer Prevention Study(CHICAPS)(CHICAPS) | completed | N/A | 8,382 | Preventive Oncology International, Inc.OTHER | 1 | May 8, 2015 | clinicaltrials |
| NCT00193830 | High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix | completed | Phase 3 | 750 | Tata Memorial HospitalOTHER_GOV | 1 | May 6, 2015 | clinicaltrials |
| NCT02235324 | Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer | withdrawn | Phase 2 | 0 | University of Southern CaliforniaOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT02431520 | Patient Compliance to Self-collection for Detection of HPV-DNA | completed | N/A | 100 | Oswaldo Cruz FoundationOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT00303823 | Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia | completed | Phase 2 | 98 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00006981 | Immunotoxin Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Dec 24, 2015source: clinicaltrials